Use of botulinum toxin type A in the prehabilitation of abdominal wall musculature for hernia repair: a consensus proposal.

Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Gea-Moreno AM
- Martínez-Hoed J
- members of the Section of Abdominal Wall of the Spanish Association of Surgeons
Abstract
The prehabilitation of the abdominal wall through the infiltration of botulinum toxin type A, which induces temporary chemical denervation ("chemical component separation") in the lateral abdominal musculature, is a common practice in units specialized in abdominal wall surgery. However, its use for this indication is currently off-label. The main objective of this article is to describe a consensus proposal regarding indications, contraindications, dosages employed, potential side effects, administration method, and measurement of possible outcomes. Additionally, a proposal for an informed consent document endorsed by the Abdominal Wall Section of the Spanish Association of Surgeons is attached.
Copyright © 2024 AEC. Published by Elsevier España, S.L.U. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 2173-5077, 2173-5077
- Tipo:
- Article
- Páginas:
- 391-399
- PubMed:
- 38342140
Cirugia Espanola
Documentos
- No hay documentos
Filiaciones
Keywords
- Botulinum toxin; Complex ventral hernia repair; Hernia con pérdida de domicilio; Hernia incisional; Hernia ventral; Incisional hernia; Loss of domain hernia; Prehabilitación; Prehabilitation; Reparación de hernia ventral compleja; Toxina botulínica; Ventral hernia
Proyectos y Estudios Clínicos
ESTUDIO CLINICO MULTICENTRICO EN FASE III ALEATORIZADO, DE DOBLE CIEGO, DE RELACION DOSIS- RESPUESTA, DE CONTROL PLACEBO Y EN GRUPOS PARALELOS PARA DETERMINAR LA EFICACIA Y TOLERABILIDAD DE LOS GRANULOS DE MESALAZINA VS PLACEBO PARA PREVENIR LA REAPARICIO N DE DIVERTICULITIS.
Investigador Principal: JUAN ANTONIO ORTUÑO CORTES
SAG-51DIV
COMPLICACIONES DE HERIDA QUIRÚRGICA EN PACIENTES INTERVENIDOS DE EVENTRACIÓN. ESTUDIO PILOTO COMPARATIVO DE APÓSITO QUIRÚRGICO CONVENCIONAL FRENTE A TERAPIA DE PRESIÓN NEGATIVA DE UN SOLO USO.
Investigador Principal: ASCENSIÓN FRANCO BERNAL
PICO